tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

UTHR Stock Latest News

Buy Rating for United Therapeutics Driven by Legal Positioning and Market Advantages Amid Patent Litigation
RatingsBuy Rating for United Therapeutics Driven by Legal Positioning and Market Advantages Amid Patent Litigation
23h ago
UTHR
Hold Rating for United Therapeutics’ Tyvaso Amid Mixed Trial Results and Real-World Applicability Concerns
PremiumRatings
Hold Rating for United Therapeutics’ Tyvaso Amid Mixed Trial Results and Real-World Applicability Concerns
4d ago
UTHR
United Therapeutics price target raised to $580 from $560 at UBS
PremiumThe Fly
United Therapeutics price target raised to $580 from $560 at UBS
4d ago
UTHR
Hold Rating Maintained for United Therapeutics’ Tyvaso Amid Competitive Landscape and Pending Data
PremiumRatings
Hold Rating Maintained for United Therapeutics’ Tyvaso Amid Competitive Landscape and Pending Data
4d ago
UTHR
CarMax downgraded, Kenvue upgraded: Wall Street’s top analyst calls
PremiumThe Fly
CarMax downgraded, Kenvue upgraded: Wall Street’s top analyst calls
7d ago
V
V
Buy Rating for United Therapeutics Amid Favorable Legal Standing in Patent Litigation
PremiumRatingsBuy Rating for United Therapeutics Amid Favorable Legal Standing in Patent Litigation
7d ago
UTHR
United Therapeutics initiated with an Outperform at RBC Capital
Premium
The Fly
United Therapeutics initiated with an Outperform at RBC Capital
7d ago
UTHR
United Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
United Therapeutics management to meet with Cantor Fitzgerald
17d ago
UTHR
United Therapeutics price target raised to $525 from $405 at Cantor Fitzgerald
PremiumThe Fly
United Therapeutics price target raised to $525 from $405 at Cantor Fitzgerald
23d ago
UTHR
United Therapeutics price target raised to $575 from $510 at Oppenheimer
PremiumThe Fly
United Therapeutics price target raised to $575 from $510 at Oppenheimer
28d ago
UTHR
United Therapeutics price target raised to $500 from $400 at H.C. Wainwright
PremiumThe Fly
United Therapeutics price target raised to $500 from $400 at H.C. Wainwright
28d ago
UTHR
United Therapeutics price target raised to $560 from $415 at UBS
PremiumThe Fly
United Therapeutics price target raised to $560 from $415 at UBS
29d ago
UTHR
Buy Rating for United Therapeutics: Promising TETON-2 Trial Results Highlight Tyvaso’s Potential in IPF Treatment
PremiumRatingsBuy Rating for United Therapeutics: Promising TETON-2 Trial Results Highlight Tyvaso’s Potential in IPF Treatment
29d ago
UTHR
United Therapeutics’ Tyvaso Shines in Phase III Trial, Poised for Growth in IPF Market
Premium
Ratings
United Therapeutics’ Tyvaso Shines in Phase III Trial, Poised for Growth in IPF Market
30d ago
UTHR
Cautious Optimism for United Therapeutics Amid TETON-2 Success and Market Uncertainties
Premium
Ratings
Cautious Optimism for United Therapeutics Amid TETON-2 Success and Market Uncertainties
30d ago
UTHR
United Therapeutics: Hold Rating Amid Positive TETON-2 Results and Competitive Challenges
PremiumRatings
United Therapeutics: Hold Rating Amid Positive TETON-2 Results and Competitive Challenges
1M ago
UTHR
United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results
PremiumMarket News
United Therapeutics Stock (UTHR) Rockets 40% on Clinical Trial Results
1M ago
UTHR
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
1M ago
AMD
BLK
Kraft Heinz announces separation, Elliott builds $4B PepsiCo stake: Morning Buzz
PremiumThe Fly
Kraft Heinz announces separation, Elliott builds $4B PepsiCo stake: Morning Buzz
1M ago
AL
TU
United Therapeutics rises 34.6%
PremiumThe FlyUnited Therapeutics rises 34.6%
1M ago
UTHR
United Therapeutics price target raised to $463 from $314 at BofA
Premium
The Fly
United Therapeutics price target raised to $463 from $314 at BofA
1M ago
LQDA
UTHR
Promising Developments in United Therapeutics’ Tyvaso Drive Buy Rating Amidst IPF Treatment Advancements
Premium
Ratings
Promising Developments in United Therapeutics’ Tyvaso Drive Buy Rating Amidst IPF Treatment Advancements
1M ago
UTHR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >